title: Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation.
authors.affiliation: Department of Anesthesia, University of Washington, Seattle 98195, USA.
authors.forename: B D
authors.initials: BD
authors.lastname: Spiess
authors.forename: T
authors.initials: T
authors.lastname: Gernsheimer
authors.forename: C
authors.initials: C
authors.lastname: Vocelka
authors.forename: W L
authors.initials: WL
authors.lastname: Chandler
authors.forename: A
authors.initials: A
authors.lastname: Benak
authors.forename: J V
authors.initials: JV
authors.lastname: Joy
authors.forename: I
authors.initials: I
authors.lastname: Wright
authors.forename: B O
authors.initials: BO
authors.lastname: Hofer
mesh_terms: D000368:Aged; D000721:Ancrod / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects*; D002315:Cardiopulmonary Bypass; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced*; D010959:Tissue Plasminogen Activator / Q000378:metabolism
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D000721:Ancrod; D010959:Tissue Plasminogen Activator